Cingulate Presents at NobleCon18
April 26 2022 - 12:27PM
Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical
company utilizing its proprietary Precision Timed Release™ (PTR™)
drug delivery platform technology to build and advance a pipeline
of next-generation pharmaceutical products, today announced that
its Chairman and Chief Executive Officer, Shane J. Schaffer,
recently presented a company overview at NobleCon18 - Noble Capital
Markets’ Eighteenth Annual Investor Conference at the Hard Rock
Hotel & Casino, Hollywood, Florida.
A video webcast of the April 20 presentation may now be accessed
on the company’s website at www.cingulate.com/investors, and as
part of a complete catalog of presentations available at Noble
Capital Markets’ Conference website at www.nobleconference.com, and
on www.channelchek.com, the investor portal created by Noble. The
webcast will be archived on Cingulate’s website, the NobleCon
website, and on Channelchek.com for 90 days following the
event.
About Cingulate®
Cingulate Inc. is a clinical-stage biopharmaceutical company
utilizing its proprietary Precision Timed Release™ (PTR™) drug
delivery platform technology to build and advance a pipeline of
next-generation pharmaceutical products, designed to improve the
lives of patients suffering from frequently diagnosed conditions
characterized by burdensome daily dosing regimens and suboptimal
treatment outcomes. With an initial focus on the treatment of
Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is
identifying and evaluating additional therapeutic areas where its
PTR technology may be employed to develop future product
candidates, such as anxiety disorders.
Cingulate is headquartered in Kansas City. For more information
visit Cingulate.com
About Noble Capital Markets, Inc.
Noble Capital Markets (“Noble”) is a research driven investment
bank that has supported small & microcap companies since 1984.
As a FINRA and SEC licensed broker dealer Noble provides
institutional-quality equity research, merchant and investment
banking, and order execution services. In 2005, Noble established
NobleCon, an investor conference that has grown substantially over
the last decade. Noble launched www.channelchek.com in 2018 – an
investor community dedicated exclusively to public small and
micro-cap companies and their industries. Channelchek is the first
service to offer institutional-quality research to the public, for
FREE at every level without a subscription. More than 6,000 public
emerging growth companies are listed on the site, with growing
content including research, webcasts, podcasts, and balanced
news.
Investor Relations
Thomas DaltonHead of Investor & Public Relations, Cingulate
Inc.Tdalton@cingulate.com913-942-2301
Media Relations
Melyssa Weible Elixir Health Public
Relationsmweible@elixirhealthpr.com 201-723-5805
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jul 2023 to Jul 2024